3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Other
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Colonic Neoplasms
4
Rectal Neoplasms
3
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Surgical Wound Infection
1
Stomatitis
1
Sigmoid Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Melanoma
1
Lung Injury
1
Ileus
1
Hidrocystoma
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Febrile Neutropenia
1
Fatigue
1
Esophageal Atresia
1
Endometrial Neoplasms
1
Interventions
pembrolizumab
29
Cetuximab
11
Nivolumab
10
Fluorouracil
8
Cyclophosphamide
8
Cisplatin
8
Carboplatin
8
fludarabine
7
atezolizumab
7
Blood Specimen Collection
7
cemiplimab
6
Radiotherapy
6
Drug Therapy
6
Immune Checkpoint Inhibitors
5
Gemcitabine
5
Paclitaxel
4
Docetaxel
4
Capecitabine
4
Biopsy
4
spartalizumab
3
avelumab
3
Surveys and Questionnaires
3
Pemetrexed
3
Oncolytic Virotherapy
3
Nicotine
3
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Ipilimumab
3
Interleukin-2
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Sodium Chloride
×
Gastrointestinal
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled